{"analyses":[{"ciLowerLimit":"-2.495","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"-0.755","dispersionType":"STANDARD_DEVIATION","dispersionValue":"1.369","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.002","paramType":"Median Difference (Final Values)","paramValue":"-1.625","statisticalMethod":"t-test, 2 sided","testedNonInferiority":false}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.677","value":"1.200"},{"groupId":"OG001","spread":"1.256","value":"2.825"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"description":"The arousal score is calculated by adding the individual scores from the arousal domain (question #3, #4, #5, #6) and multiplying the sum by the domain factor of 0.3. The arousal domain score ranges from 0 (minimum) to 6 (maximum)and a higher value represents a better outcome.","dispersionType":"Standard Deviation","groups":[{"description":"Administered to participants prior to starting vaginal testosterone therapy.","id":"OG000","title":"FSFI Arousal Domain Score (Pretest)"},{"description":"Testosterone USP micronized powder supplied by Medisca Pharmacy was compounded by Precision Compounding pharmacy as testosterone 0.3% per 0.5 milliliters (mL) in pharmabase cream. The compounded testosterone vaginal cream was supplied in pre-filled syringes and each 0.5 mL dose delivered 300 mcg of testosterone daily. The cream was applied to the vaginal opening once daily for four weeks (28 days).","id":"OG001","title":"FSFI Arousal Domain Score (Posttest)"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Baseline, 4 weeks","title":"FSFI Arousal Domain","type":"PRIMARY","unitOfMeasure":"units on a scale"}